Olcotan Tablet 10mg (Olmesartan Medoxomil)
Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Kohler Pharmaceutical Co., Ltd.
MFDS item code 201100948 · Approved 2011.02.25
This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension
This medication is used to treat essential hypertension, which is hypertension of unknown cause. It lowers blood pressure reliably to reduce the burden on the heart and blood vessels, thus preventing the risk of complications. Therefore, taking it continuously helps to manage health more effectively.
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after initiation of treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to initiate treatment at a low dose while carefully monitoring their condition. <Elderly patients> No dose adjustment is necessary when administering this medicine to elderly patients aged 65 years or older. Although no overall differences in the efficacy and safety of this medicine have been observed between elderly and younger patients, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. For patients with moderate hepatic impairment, the recommended initial dose is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
<Pediatrics> The safety and efficacy in pediatric patients have not been established.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, thus it should be discontinued immediately upon confirmation of pregnancy. Patients with hypersensitivity to the components of this medication, pregnant and breastfeeding women, patients on kidney dialysis, those with severe liver impairment, patients with biliary obstruction, specific genetic lactose intolerance, and certain diabetes patients should not use this medication. Patients with reduced blood volume or salt may experience hypotension, so careful monitoring and appropriate measures are necessary before administering this medication. Patients with impaired kidney function or those who have received a kidney transplant should have their kidney function and serum potassium levels regularly monitored, and it is not recommended for those with severe kidney impairment. This medication may cause hyperkalemia, so patients with heart failure or kidney disorders should carefully monitor their serum potassium levels. Patients with aortic or mitral stenosis, obstruction, and hypertrophic cardiomyopathy require special caution. Dizziness may occur due to blood pressure-lowering effects, so caution should be exercised during high-risk activities such as working at heights or driving. Mild and transient side effects such as dizziness, headache, back pain, dyspepsia may occur, and rare reports of angioedema or liver function abnormalities have been noted. Prolonged use may lead to chronic diarrhea and chronic malabsorption-like intestinal diseases, so patients should consult a doctor if intestinal symptoms occur. When taken with potassium-sparing diuretics or potassium supplements, serum potassium levels may increase to dangerous levels, so caution is needed when used in combination. Taking this medication with other antihypertensives may enhance blood pressure-lowering effects, so patients must inform their doctor of other medications they are taking. Combining with lithium may raise serum lithium levels and cause toxicity, therefore this combination is not recommended. Taking with non-steroidal anti-inflammatory drugs may increase the risk of kidney function decline, thus hydration and monitoring of kidney function are necessary. In pregnant women, there is a risk of fetal damage, so this medication should be avoided during pregnancy, and breastfeeding should be discontinued or discussed with a doctor. Safety for children has not been adequately established, so this medication should be administered cautiously to children. Elderly patients may experience increased drug concentration in the body, requiring dose adjustment and caution. In the event of overdose, hypotension and palpitations may occur, and appropriate treatment should be initiated based on symptoms. This medication has been reported to have a low risk of carcinogenicity or genotoxicity; however, rare cellular-level changes have been observed. During the course of this medication, it is important to have regular health check-ups and follow the physician's instructions closely.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to avoid exposure to air or moisture. It is important to keep the storage temperature between 1 and 25 degrees Celsius.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Kohler Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.